(2S)-6-[[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]acetyl]amino]-2-[[(2R)-2-(benzylsulfonylamino)-3-hydroxy-propanoyl]amino]-N-[(4-carbamimidoylphenyl)methyl]hexanamide; 2,2,2-trifluoroacetic acid::US8476306, 10

ID: ALA3648001

Chembl Id: CHEMBL3648001

PubChem CID: 59558200

Max Phase: Preclinical

Molecular Formula: C44H72N8O15S

Molecular Weight: 985.17

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(N)c1ccc(CNC(=O)[C@H](CCCCNC(=O)COCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCN)NC(=O)[C@@H](CO)NS(=O)(=O)Cc2ccccc2)cc1

Standard InChI:  InChI=1S/C44H72N8O15S/c45-13-16-60-18-20-62-22-24-64-26-28-66-29-27-65-25-23-63-21-19-61-17-15-49-41(55)33-67-32-40(54)48-14-5-4-8-38(43(56)50-30-35-9-11-37(12-10-35)42(46)47)51-44(57)39(31-53)52-68(58,59)34-36-6-2-1-3-7-36/h1-3,6-7,9-12,38-39,52-53H,4-5,8,13-34,45H2,(H3,46,47)(H,48,54)(H,49,55)(H,50,56)(H,51,57)/t38-,39+/m0/s1

Standard InChI Key:  WWDFPEZFNGBGEX-ZESVVUHVSA-N

Associated Targets(non-human)

Plaur Urokinase plasminogen activator surface receptor (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plg Plasminogen (125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Thrombin (98 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prss1 Anionic trypsin-1 (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 985.17Molecular Weight (Monoisotopic): 984.4838AlogP: -1.95#Rotatable Bonds: 43
Polar Surface Area: 332.53Molecular Species: BASEHBA: 17HBD: 9
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 11#RO5 Violations (Lipinski): 3
CX Acidic pKa: 8.39CX Basic pKa: 11.36CX LogP: -4.02CX LogD: -6.93
Aromatic Rings: 2Heavy Atoms: 68QED Weighted: 0.02Np Likeness Score: -0.51

References

1.  (2013)  Urokinase inhibitors, production and use thereof, 

Source

Source(1):